
### [MONDO:0020162](http://purl.obolibrary.org/obo/MONDO_0020162)
**Label:** secondary ectropion

**Subclasses:** [MONDO:0011680](http://purl.obolibrary.org/obo/MONDO_0011680) (autosomal recessive congenital ichthyosis 3), [MONDO:0017778](http://purl.obolibrary.org/obo/MONDO_0017778) (lamellar ichthyosis), [MONDO:0011485](http://purl.obolibrary.org/obo/MONDO_0011485) (autosomal recessive congenital ichthyosis 5), [MONDO:0013495](http://purl.obolibrary.org/obo/MONDO_0013495) (autosomal recessive congenital ichthyosis 8), [MONDO:0008853](http://purl.obolibrary.org/obo/MONDO_0008853) (Barber-Say syndrome), [MONDO:0009910](http://purl.obolibrary.org/obo/MONDO_0009910) (Wiedemann-Rautenstrauch syndrome), [MONDO:0000136](http://purl.obolibrary.org/obo/MONDO_0000136) (keratosis follicularis spinulosa decalvans), [MONDO:0009903](http://purl.obolibrary.org/obo/MONDO_0009903) (postaxial acrofacial dysostosis), [MONDO:0007922](http://purl.obolibrary.org/obo/MONDO_0007922) (lymphedema-distichiasis syndrome), [MONDO:0007812](http://purl.obolibrary.org/obo/MONDO_0007812) (ichthyosis, lamellar, autosomal dominant), [MONDO:0010637](http://purl.obolibrary.org/obo/MONDO_0010637) (keratosis follicularis spinulosa decalvans, X-linked), [MONDO:0007201](http://purl.obolibrary.org/obo/MONDO_0007201) (blepharophimosis, ptosis, and epicanthus inversus syndrome), [MONDO:0016859](http://purl.obolibrary.org/obo/MONDO_0016859) (blepharophimosis-epicanthus inversus-ptosis due to copy number variations), [MONDO:0011026](http://purl.obolibrary.org/obo/MONDO_0011026) (autosomal recessive congenital ichthyosis 4A), [MONDO:0012847](http://purl.obolibrary.org/obo/MONDO_0012847) (autosomal recessive congenital ichthyosis 6), [MONDO:0013018](http://purl.obolibrary.org/obo/MONDO_0013018) (keratosis follicularis spinulosa decalvans, autosomal dominant), [MONDO:0016858](http://purl.obolibrary.org/obo/MONDO_0016858) (blepharophimosis-epicanthus inversus-ptosis due to a point mutation syndrome), [MONDO:0016857](http://purl.obolibrary.org/obo/MONDO_0016857) (blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0034191](http://purl.obolibrary.org/obo/GO_0034191) (apolipoprotein A-I receptor binding), [GO:0003688](http://purl.obolibrary.org/obo/GO_0003688) (DNA replication origin binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0071930](http://purl.obolibrary.org/obo/GO_0071930) (negative regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0019369](http://purl.obolibrary.org/obo/GO_0019369) (arachidonic acid metabolic process), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0042703](http://purl.obolibrary.org/obo/GO_0042703) (menstruation), [GO:2000010](http://purl.obolibrary.org/obo/GO_2000010) (positive regulation of protein localization to cell surface), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0046620](http://purl.obolibrary.org/obo/GO_0046620) (regulation of organ growth), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0044205](http://purl.obolibrary.org/obo/GO_0044205) ('de novo' UMP biosynthetic process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0048496](http://purl.obolibrary.org/obo/GO_0048496) (maintenance of animal organ identity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0048010](http://purl.obolibrary.org/obo/GO_0048010) (vascular endothelial growth factor receptor signaling pathway), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0019233](http://purl.obolibrary.org/obo/GO_0019233) (sensory perception of pain), [GO:0019237](http://purl.obolibrary.org/obo/GO_0019237) (centromeric DNA binding), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0015095](http://purl.obolibrary.org/obo/GO_0015095) (magnesium ion transmembrane transporter activity), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0043129](http://purl.obolibrary.org/obo/GO_0043129) (surfactant homeostasis), [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0051300](http://purl.obolibrary.org/obo/GO_0051300) (spindle pole body organization), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0046881](http://purl.obolibrary.org/obo/GO_0046881) (positive regulation of follicle-stimulating hormone secretion), [GO:0010875](http://purl.obolibrary.org/obo/GO_0010875) (positive regulation of cholesterol efflux), [GO:0019101](http://purl.obolibrary.org/obo/GO_0019101) (female somatic sex determination), [GO:0033630](http://purl.obolibrary.org/obo/GO_0033630) (positive regulation of cell adhesion mediated by integrin), [GO:0060014](http://purl.obolibrary.org/obo/GO_0060014) (granulosa cell differentiation), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis), [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:1990440](http://purl.obolibrary.org/obo/GO_1990440) (positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0004402](http://purl.obolibrary.org/obo/GO_0004402) (histone acetyltransferase activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0072112](http://purl.obolibrary.org/obo/GO_0072112) (glomerular visceral epithelial cell differentiation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0033625](http://purl.obolibrary.org/obo/GO_0033625) (positive regulation of integrin activation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0045171](http://purl.obolibrary.org/obo/GO_0045171) (intercellular bridge), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0045055](http://purl.obolibrary.org/obo/GO_0045055) (regulated exocytosis), [GO:0016573](http://purl.obolibrary.org/obo/GO_0016573) (histone acetylation), [GO:0090419](http://purl.obolibrary.org/obo/GO_0090419) (negative regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0032918](http://purl.obolibrary.org/obo/GO_0032918) (spermidine acetylation), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0033686](http://purl.obolibrary.org/obo/GO_0033686) (positive regulation of luteinizing hormone secretion), [GO:0035627](http://purl.obolibrary.org/obo/GO_0035627) (ceramide transport), [GO:0044092](http://purl.obolibrary.org/obo/GO_0044092) (negative regulation of molecular function), [GO:0072659](http://purl.obolibrary.org/obo/GO_0072659) (protein localization to plasma membrane), [GO:0016788](http://purl.obolibrary.org/obo/GO_0016788) (hydrolase activity, acting on ester bonds), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0015693](http://purl.obolibrary.org/obo/GO_0015693) (magnesium ion transport), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0048341](http://purl.obolibrary.org/obo/GO_0048341) (paraxial mesoderm formation), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0048343](http://purl.obolibrary.org/obo/GO_0048343) (paraxial mesodermal cell fate commitment), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0019809](http://purl.obolibrary.org/obo/GO_0019809) (spermidine binding), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0047812](http://purl.obolibrary.org/obo/GO_0047812) (D-amino-acid N-acetyltransferase activity), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0001974](http://purl.obolibrary.org/obo/GO_0001974) (blood vessel remodeling), [GO:0019372](http://purl.obolibrary.org/obo/GO_0019372) (lipoxygenase pathway), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0031124](http://purl.obolibrary.org/obo/GO_0031124) (mRNA 3'-end processing), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0090055](http://purl.obolibrary.org/obo/GO_0090055) (positive regulation of chromatin silencing at silent mating-type cassette), [GO:0090050](http://purl.obolibrary.org/obo/GO_0090050) (positive regulation of cell migration involved in sprouting angiogenesis), [GO:0007535](http://purl.obolibrary.org/obo/GO_0007535) (donor selection), [GO:0004145](http://purl.obolibrary.org/obo/GO_0004145) (diamine N-acetyltransferase activity), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0051122](http://purl.obolibrary.org/obo/GO_0051122) (hepoxilin biosynthetic process), [GO:0051120](http://purl.obolibrary.org/obo/GO_0051120) (hepoxilin A3 synthase activity), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0004152](http://purl.obolibrary.org/obo/GO_0004152) (dihydroorotate dehydrogenase activity), [GO:0009725](http://purl.obolibrary.org/obo/GO_0009725) (response to hormone), [GO:0031624](http://purl.obolibrary.org/obo/GO_0031624) (ubiquitin conjugating enzyme binding), [GO:0006207](http://purl.obolibrary.org/obo/GO_0006207) ('de novo' pyrimidine nucleobase biosynthetic process), [GO:0071406](http://purl.obolibrary.org/obo/GO_0071406) (cellular response to methylmercury), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0036500](http://purl.obolibrary.org/obo/GO_0036500) (ATF6-mediated unfolded protein response), [GO:0010595](http://purl.obolibrary.org/obo/GO_0010595) (positive regulation of endothelial cell migration), [GO:0032940](http://purl.obolibrary.org/obo/GO_0032940) (secretion by cell), [GO:0031293](http://purl.obolibrary.org/obo/GO_0031293) (membrane protein intracellular domain proteolysis), [GO:0055088](http://purl.obolibrary.org/obo/GO_0055088) (lipid homeostasis), [GO:0043651](http://purl.obolibrary.org/obo/GO_0043651) (linoleic acid metabolic process), [GO:0002074](http://purl.obolibrary.org/obo/GO_0002074) (extraocular skeletal muscle development), [GO:0090282](http://purl.obolibrary.org/obo/GO_0090282) (positive regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development), [GO:0001656](http://purl.obolibrary.org/obo/GO_0001656) (metanephros development), [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0070458](http://purl.obolibrary.org/obo/GO_0070458) (cellular detoxification of nitrogen compound), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0048039](http://purl.obolibrary.org/obo/GO_0048039) (ubiquinone binding), [GO:0006369](http://purl.obolibrary.org/obo/GO_0006369) (termination of RNA polymerase II transcription), [GO:0043028](http://purl.obolibrary.org/obo/GO_0043028) (cysteine-type endopeptidase regulator activity involved in apoptotic process), [GO:0007338](http://purl.obolibrary.org/obo/GO_0007338) (single fertilization), [GO:0046416](http://purl.obolibrary.org/obo/GO_0046416) (D-amino acid metabolic process), [GO:0048286](http://purl.obolibrary.org/obo/GO_0048286) (lung alveolus development), [GO:0043392](http://purl.obolibrary.org/obo/GO_0043392) (negative regulation of DNA binding), [GO:1990841](http://purl.obolibrary.org/obo/GO_1990841) (promoter-specific chromatin binding), [GO:0048048](http://purl.obolibrary.org/obo/GO_0048048) (embryonic eye morphogenesis), [GO:0072144](http://purl.obolibrary.org/obo/GO_0072144) (glomerular mesangial cell development), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0097209](http://purl.obolibrary.org/obo/GO_0097209) (epidermal lamellar body), [GO:0035357](http://purl.obolibrary.org/obo/GO_0035357) (peroxisome proliferator activated receptor signaling pathway), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0035470](http://purl.obolibrary.org/obo/GO_0035470) (positive regulation of vascular wound healing), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0090140](http://purl.obolibrary.org/obo/GO_0090140) (regulation of mitochondrial fission), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0051213](http://purl.obolibrary.org/obo/GO_0051213) (dioxygenase activity), [GO:0072011](http://purl.obolibrary.org/obo/GO_0072011) (glomerular endothelium development), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0016165](http://purl.obolibrary.org/obo/GO_0016165) (linoleate 13S-lipoxygenase activity), [GO:0030331](http://purl.obolibrary.org/obo/GO_0030331) (estrogen receptor binding), [GO:0031424](http://purl.obolibrary.org/obo/GO_0031424) (keratinization), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0016702](http://purl.obolibrary.org/obo/GO_0016702) (oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen), [GO:0060065](http://purl.obolibrary.org/obo/GO_0060065) (uterus development), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:1902257](http://purl.obolibrary.org/obo/GO_1902257) (negative regulation of apoptotic process involved in outflow tract morphogenesis), [GO:0006221](http://purl.obolibrary.org/obo/GO_0006221) (pyrimidine nucleotide biosynthetic process), [GO:1903468](http://purl.obolibrary.org/obo/GO_1903468) (positive regulation of DNA replication initiation), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0010838](http://purl.obolibrary.org/obo/GO_0010838) (positive regulation of keratinocyte proliferation), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0001569](http://purl.obolibrary.org/obo/GO_0001569) (branching involved in blood vessel morphogenesis), [GO:0008080](http://purl.obolibrary.org/obo/GO_0008080) (N-acetyltransferase activity), [GO:0034244](http://purl.obolibrary.org/obo/GO_0034244) (negative regulation of transcription elongation from RNA polymerase II promoter), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0006595](http://purl.obolibrary.org/obo/GO_0006595) (polyamine metabolic process), [GO:0046208](http://purl.obolibrary.org/obo/GO_0046208) (spermine catabolic process), [GO:0006598](http://purl.obolibrary.org/obo/GO_0006598) (polyamine catabolic process), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0032298](http://purl.obolibrary.org/obo/GO_0032298) (positive regulation of DNA-dependent DNA replication initiation), [GO:2000221](http://purl.obolibrary.org/obo/GO_2000221) (negative regulation of pseudohyphal growth), [GO:2000583](http://purl.obolibrary.org/obo/GO_2000583) (regulation of platelet-derived growth factor receptor-alpha signaling pathway), [GO:0033700](http://purl.obolibrary.org/obo/GO_0033700) (phospholipid efflux), 

**Class expressions from DL-Learner:**

- Thing 55.65%
- [GO:0070458](http://purl.obolibrary.org/obo/GO_0070458) (cellular detoxification of nitrogen compound) 50.64%
- [GO:0060065](http://purl.obolibrary.org/obo/GO_0060065) (uterus development) 50.64%
- [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation) 50.64%
- [GO:0051410](http://purl.obolibrary.org/obo/GO_0051410) (detoxification of nitrogen compound) 50.64%
- [GO:0042703](http://purl.obolibrary.org/obo/GO_0042703) (menstruation) 50.64%
- [GO:0030237](http://purl.obolibrary.org/obo/GO_0030237) (female sex determination) 50.64%
- [GO:0019101](http://purl.obolibrary.org/obo/GO_0019101) (female somatic sex determination) 50.64%
- [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization) 50.64%
- [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development) 50.64%
- [GO:0007338](http://purl.obolibrary.org/obo/GO_0007338) (single fertilization) 50.64%
- [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development) 50.64%
- [GO:0051410](http://purl.obolibrary.org/obo/GO_0051410) (detoxification of nitrogen compound) and [GO:1990748](http://purl.obolibrary.org/obo/GO_1990748) (cellular detoxification) 50.64%
- [GO:0018993](http://purl.obolibrary.org/obo/GO_0018993) (somatic sex determination) and [GO:0030237](http://purl.obolibrary.org/obo/GO_0030237) (female sex determination) 50.64%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 43.39%


